Repeated access to sucrose augments dopamine turnover in the nucleus accumbens

NeuroReport

Volumn 13, Issue 17, 2002, Pages 2213-2216

  Hajnal, Andras ^a   Norgren, Ralph ^a  

^a PENN STATE COLLEGE OF MEDICINE   (United States)

Author keywords

Binge eating; Dopamine release; Dopamine uptake; Latent inhibition; Microdialysis; Neuroadaptation; Restricted feeding; Reward sensitization; Sugar

Indexed keywords

SUCROSE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOPAMINE BRAIN LEVEL; DOPAMINE METABOLISM; DOPAMINE RELEASE; FEEDING; FOOD PREFERENCE; MALE; MICRODIALYSIS; NONHUMAN; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; RAT;

ADAPTATION, PHYSIOLOGICAL; ANIMALS; CUES; DOPAMINE; EATING DISORDERS; EXTRACELLULAR SPACE; FEEDING BEHAVIOR; FOOD DEPRIVATION; HABITUATION, PSYCHOPHYSIOLOGIC; MALE; MICRODIALYSIS; NEURAL PATHWAYS; NEURONS; NUCLEUS ACCUMBENS; RATS; RATS, SPRAGUE-DAWLEY; SUCROSE; SYNAPTIC TRANSMISSION; UP-REGULATION;

EID: 0037016138     PISSN: 09594965     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001756-200212030-00010     Document Type: Article

References (25)

1. Hagan MM and Moss DE. Int J Eat Disord 22, 411-420 (1997).
2. Carr KD. Neurochem Res 21, 1455-1467 (1996).
3. Cabeza DV and Carr KD. J Neurosci 18, 7502-7510 (1998).
4. Specker SM, Lac ST and Carroll ME. Pharmacol Biochem Behav 48, 1025-1029 (1994).
5. Colantuoni C, Schwenker J, McCarthy J et al. Neuroreport 12, 3549-3552 (2001).
6. Colantuoni C, Rada P, McCarthy J et al. Obes Res 10, 478-488 (2002).
7. Sclafani A. Neurosci Biobehav Rev 11, 131-153 (1987).
8. Weingarten HP and Watson SD. Physiol Behav 28, 401-407 (1982).
9. Geary N and Smith GP. Pharmacol Biochem Behav 22, 787-790 (1985).
10. Nissenbaum JW and Sclafani A. Neurosci Biobehav Rev 11, 215-222 (1987).
11. Smith GP. Prog Psychobiol Physiol Psychol 16, 83-144 (1995).
12. Hajnal A and Norgren R. Brain Res 904, 76-84 (2001).
13. Hajnal A, Smith GP, Norgren R. Appetite 37, 141-142 (2001).
14. Sclafani A and Ackroff K. Physiol Behav 53, 1091-1099 (1993).
15. Bassareo V and Di Chiara G. Eur J Neurosci 11, 4389-4397 (1999).
16. Pothos EN, Creese I and Hoebel BG. J Neurosci 15, 6640-6650 (1995).
17. Morgan AE, Porter SP, Clarkson FA et al. Synapse 26, 423-427 (1997).
18. Harmer CJ and Phillips GD. Behav Pharmacol 9, 299-308 (1998).
19. Shilling PD, Kelsoe JR and Segal DS. Neurosci Lett 236, 131-134 (1997).
20. Cass WA, Zahniser NR, Flach KA et al. J Neurochem 61, 2269-2278 (1993).
21. Zahniser NR, Larson GA and Gerhardt GA. J Pharmacol Exp Ther 289, 266-277 (1999).
22. Kuczenski R, Segal DS and Todd PK. Psychopharmacology (Berl) 134, 221-229 (1997).
23. Di Chiara G. J Psychopharmacol 12, 54-67 (1998).
24. Bello NT, Lucas LR and Hajnal A. Neuroreport 13, 1575-1578 (2002).
25. Koob GF and Le Moal M. Neuropsychopharmacology 24, 97-129 (2001).